PA
Profund Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
24,263
-4,644
| -16% | -$226K | 0.04% | 263 |
|
|
2025
Q1 | $984K | Sell |
28,907
-1,526
| -5% | -$51.9K | 0.04% | 298 |
|
|
2024
Q4 | $1.2M | Sell |
30,433
-10,064
| -25% | -$396K | 0.04% | 267 |
|
|
2024
Q3 | $1.9M | Buy |
40,497
+8,081
| +25% | +$380K | 0.07% | 195 |
|
|
2024
Q2 | $1.75M | Buy |
32,416
+14,820
| +84% | +$800K | 0.06% | 194 |
|
|
2024
Q1 | $1.2M | Sell |
17,596
-4,355
| -20% | -$297K | 0.05% | 310 |
|
|
2023
Q4 | $1.37M | Sell |
21,951
-7,317
| -25% | -$458K | 0.06% | 263 |
|
|
2023
Q3 | $1.33M | Buy |
29,268
+5,184
| +22% | +$235K | 0.07% | 224 |
|
|
2023
Q2 | $1.35M | Sell |
24,084
-4,525
| -16% | -$254K | 0.07% | 241 |
|
|
2023
Q1 | $1.29M | Buy |
28,609
+19,876
| +228% | +$899K | 0.08% | 228 |
|
|
2022
Q4 | $355K | Buy |
8,733
+227
| +3% | +$9.23K | 0.02% | 555 |
|
|
2022
Q3 | $556K | Buy |
8,506
+364
| +4% | +$23.8K | 0.04% | 360 |
|
|
2022
Q2 | $495K | Sell |
8,142
-629
| -7% | -$38.2K | 0.03% | 414 |
|
|
2022
Q1 | $551K | Buy |
+8,771
| New | +$551K | 0.02% | 511 |
|